Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma

PURPOSE: Idiotypes (Ids), the unique portions of tumor immunoglobulins, can serve as targets for passive and active immunotherapies for lymphoma. We performed a multicenter, randomized trial comparing a specific vaccine (MyVax), comprising Id chemically coupled to keyhole limpet hemocyanin (KLH) plu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Levy, Ronald, Ganjoo, Kristen N., Leonard, John P., Vose, Julie M., Flinn, Ian W., Ambinder, Richard F., Connors, Joseph M., Berinstein, Neil L., Belch, Andrew R., Bartlett, Nancy L., Nichols, Craig, Emmanouilides, Christos E., Timmerman, John M., Gregory, Stephanie A., Link, Brian K., Inwards, David J., Freedman, Arnold S., Matous, Jeffrey V., Robertson, Michael J., Kunkel, Lori A., Ingolia, Diane E., Gentles, Andrew J., Liu, Chih Long, Tibshirani, Robert, Alizadeh, Ash A., Denney, Dan W.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2014
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4039868/
https://ncbi.nlm.nih.gov/pubmed/24799467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.43.9273
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars